Should we continue to use benzathine penicillin for rheumatic fever prophylaxis?
dc.contributor.author | Jayakody, R.L. | |
dc.contributor.author | Kottegoda, S. | |
dc.date.accessioned | 2016-01-14T08:39:39Z | |
dc.date.available | 2016-01-14T08:39:39Z | |
dc.date.issued | 1993 | |
dc.identifier.citation | The Ceylon Medical Journal, 38(4)pp.171-173 | |
dc.identifier.uri | https://dl.nsf.gov.lk/handle/1/20438 | |
dc.publisher | The Sri Lanka Medical Association:Colombo | |
dc.subject | Medical Sciences | |
dc.subject | Allergic reactions | |
dc.subject | Pharmacology | |
dc.subject | Hypersensitivity | |
dc.subject | Drug toxicology | |
dc.subject | Anaphylaxis | |
dc.title | Should we continue to use benzathine penicillin for rheumatic fever prophylaxis? | |
dc.type | Article |